The hexosamine biosynthesis pathway as a potent culprit in breast cancer progression
The Journal of Steroid Biochemistry and Molecular Biology · 2026-03 · 257 · 106932
DOI: 10.1016/j.jsbmb.2025.106932 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2026-03. Verfasst von Maryam Musavi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran; Department of Medical Biotechnology, School of M…. Hauptthemen laut MEDLINE: Hexosamines, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben.
Abstract (Originalsprache)
The hexosamine biosynthesis pathway (HBP) is a nutrient-sensitive branch of glucose metabolism that produces UDP-GlcNAc, a central substrate for protein glycosylation. Growing evidence links altered HBP activity to breast cancer (BC) progression and treatment response. However, the strength of evidence differs across tumor subtypes and across experimental versus patient data. This review summarizes current clinical and preclinical evidence on how HBP enzymes and HBP-derived glycosylation contribute to BC biology. Across BC cohorts and experimental models, increased expression of key HBP components has been associated with aggressive features, while mechanistic studies show that HBP activity can support oncogenic signaling through elevated O-GlcNAcylation of regulatory proteins. Work in BC models further indicates that HBP-related changes influence proliferation, survival, epithelial-mesenchymal transition, migration, and invasion, and may interact with pathways such as PI3K/AKT/mTOR, Wnt/β-catenin, and YAP. Evidence discussed in this review also links HBP output to stress-adaptation programs, including DNA damage responses and ER protein-folding capacity via N-linked glycosylation, which can promote survival under nutrient or therapy stress. Therapeutic studies described here include direct and indirect strategies to reduce HBP output, such as targeting pathway enzymes, modulating O-GlcNAc cycling, and using hexosamine analogs designed to disrupt flux or glycan function; these approaches reduce growth and metastatic behavior in several preclinical settings, but specificity and normal-tissue tolerance remain key constraints. Overall, the literature supports HBP as a plausible metabolic contributor to BC progression, but stronger patient-linked validation is needed. Future work should prioritize subtype-resolved clinical studies and direct measures of pathway activity to guide biomarker development and therapeutic targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran; Department of Medical Biotechnology, School of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran.
- Department of Physiology, Tabriz University of Medical Sciences, Tabriz, Iran.
- Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Nutrition, Clinical Biochemistry and Food Sciences, School of Medicine, Gonabad University of Medical Sciences, Gonabad, Iran. Electronic address: ghasemi.a51@gmail.com.
- Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran; Department of Medical Biotechnology, School of Medicine, Neyshabur University of Medical Sciences, Neyshabur, Iran. El…
Zitieren
APA
Musavi, M., Oghbaei, F., Abavisani, M., Ghasemi, A., & Momtazi-Borojeni, A. A. (2026). The hexosamine biosynthesis pathway as a potent culprit in breast cancer progression. The Journal of Steroid Biochemistry and Molecular Biology, 257, 106932. https://doi.org/10.1016/j.jsbmb.2025.106932
Vancouver
Musavi M, Oghbaei F, Abavisani M, Ghasemi A, Momtazi-Borojeni AA. The hexosamine biosynthesis pathway as a potent culprit in breast cancer progression. The Journal of Steroid Biochemistry and Molecular Biology. 2026;257:106932. doi:10.1016/j.jsbmb.2025.106932
BibTeX
@article{Musavi2026,
author = {Musavi, Maryam and Oghbaei, Farnaz and Abavisani, Mohammad and Ghasemi, Ahmad and Momtazi-Borojeni, Amir Abbas},
title = {The hexosamine biosynthesis pathway as a potent culprit in breast cancer progression},
journal = {The Journal of Steroid Biochemistry and Molecular Biology},
year = {2026},
volume = {257},
pages = {106932},
doi = {10.1016/j.jsbmb.2025.106932}
}
EUVIMED